Domini Impact Investments’s RESPONSE GENETICS, INC COMMON SHS (DELAWARE) RGDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-36,561
Closed -$25K 14
2014
Q3
$25K Buy
36,561
+10,066
+38% +$7.89K 0.66% 14
2014
Q2
$24K Buy
26,495
+6,348
+32% +$6.64K 1.02% 10
2014
Q1
$24K Buy
20,147
+1,270
+7% +$1.77K 1.38% 9
2013
Q4
$22K Buy
+18,877
New +$30.9K 1.6% 8

Other funds holding RGDX

Domini Impact Investments's RGDX Position: Q4 2014 in Review

Domini Impact Investments sold out of RESPONSE GENETICS, INC COMMON SHS (DELAWARE) (RGDX) in Q4 2014, closing a stake of 36,561 shares — an estimated $25K sold.

Domini Impact Investments first reported a position in RGDX in Q4 2013 and held it in 4 quarters. The position peaked at $25K in Q3 2014. 16 funds tracked by Wall St. Rank hold RGDX as of Q4 2014.

  • Domini Impact Investments reported no remaining RESPONSE GENETICS, INC COMMON SHS (DELAWARE) position as of Q4 2014 after selling out during the quarter.
  • Domini Impact Investments sold 36,561 RESPONSE GENETICS, INC COMMON SHS (DELAWARE) shares in Q4 2014, an estimated $25K.
  • Domini Impact Investments first reported a position in RESPONSE GENETICS, INC COMMON SHS (DELAWARE) in Q4 2013 and held it in 4 quarters.
  • Domini Impact Investments's RESPONSE GENETICS, INC COMMON SHS (DELAWARE) position peaked at $25K in Q3 2014.
  • 16 funds tracked by Wall St. Rank held RESPONSE GENETICS, INC COMMON SHS (DELAWARE) as of Q4 2014.

Based on Domini Impact Investments's 13F filing for Q4 2014, filed 12 Feb 2015.